There is no such thing as a legally defined pregnancy safe cosmetic in EU law. No annex creates the category, no authorisation route exists for it, and no regulator certifies it. What exists is a set of substances where developmental or endocrine concerns are documented, and a customer group that reads ingredient lists more carefully than any other in the market.
That gap between a strong commercial demand and no legal framework is where brands get into trouble. This guide covers which substances actually matter, what you may and may not say on the pack, and how a targeted safety assessment for this audience differs from a standard CPSR.
Key takeaways
- EU law has no “pregnancy safe” category. The phrase is a marketing claim like any other and must satisfy Regulation (EU) No 655/2013.
- A claim implying medical reassurance can be challenged, and so can one implying competitors are unsafe.
- Retinoids are the first thing this customer group looks for. Regulation (EU) 2024/996 already set vitamin A limits in cosmetics.
- Salicylic acid and other BHAs at leave-on treatment concentrations are the second.
- Phytoestrogens such as genistein and daidzein were addressed by the same 2024 amendment.
- Essential oils traditionally flagged in pregnancy need assessing at your finished concentration, not by reputation.
- The assessment is a full CPSR plus a targeted reproductive and developmental review, which is genuinely more work.
- The defensible position is formulated without X, substantiated, not safe for pregnancy, asserted.
Why the claim is the risk, not the formula
Most cosmetics marketed to pregnant customers are perfectly ordinary products with a careful ingredient policy. The formula is rarely the problem. The problem is what the pack says about it.
Regulation (EU) No 655/2013 lays down common criteria for cosmetic claims: legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making. A “safe for pregnancy” claim runs into several of them at once.
It implies a level of assurance that no cosmetic safety assessment can give, since a CPSR concludes on the safety of a product for its intended use rather than certifying an outcome for a pregnancy. It edges towards a health claim, which cosmetics may not make. And in a category built on fear of ingredients, it can imply that competing products are unsafe, which the fairness criterion prohibits.
Our guide to what cosmetic claims are allowed in the EU covers the common criteria in full, and greenwashing in cosmetics covers the enforcement direction of travel on claim substantiation generally.
The two claims most likely to attract a challenge are “safe for pregnancy”, because it implies medical reassurance a cosmetic cannot give, and “pregnancy safe” used as a category badge across a range without product-by-product substantiation. Both invite the question no brand wants to answer in writing: safe on what evidence, and compared with what?
The substances that actually matter
Retinoids and vitamin A
This is the first thing the customer checks and the first thing to get right. Retinol, retinyl palmitate, retinyl acetate and retinaldehyde all contribute to vitamin A exposure, and systemic vitamin A at high doses is a known developmental concern. Regulation (EU) 2024/996 set maximum concentrations for vitamin A in cosmetics, with a lower limit for body lotion than for other leave-on products because of the applied amount.
Note that being within the legal limit and being suitable for a pregnancy-positioned range are different questions. The limit is a general population limit; your positioning is a commercial choice you then have to be able to defend.
Salicylic acid and beta hydroxy acids
Salicylic acid has its own Annex III entry with concentration limits and product-type conditions, and it carries an age restriction excluding children under three outside shampoos. It is the acid this audience asks about most, usually because of the oral aspirin comparison rather than because of dermal data, but that distinction is not one a label can win an argument about.
Phytoestrogens and endocrine-activity concerns
Regulation (EU) 2024/996 also addressed genistein and daidzein, phytoestrogens found in soy-derived actives. Substances flagged for potential endocrine activity are an active area of EU review, and formulating around them is one of the more defensible things a pregnancy-positioned range can actually do.
Essential oils
Traditional pregnancy advice about essential oils is largely inherited from aromatherapy practice rather than derived from dermal toxicology, but it is what your customer believes. The regulatory work is the same as for any botanical: identify the actual constituents, check them against Annex III, and calculate the exposure at your finished concentration rather than debating the oil by reputation. Our article on essential oils in cosmetics covers how restricted constituents arrive through the oil.
UV filters and other systemic questions
Certain UV filters have attracted attention over systemic absorption, which is why a pregnancy-positioned sun care product usually leans mineral. If you make an SPF claim, Annex VI compliance and substantiated SPF testing apply regardless of the positioning.
What you can defensibly say
| Wording | Position | Why |
|---|---|---|
| “Safe for pregnancy” | Avoid | Implies medical reassurance a cosmetic cannot give |
| “Pregnancy safe” as a range badge | Avoid | Category claim with no per-product substantiation |
| “Approved for use in pregnancy” | Avoid | No EU approval scheme exists; the claim is false |
| “Formulated without retinol and salicylic acid” | Defensible | Factual, verifiable, no safety implication about others |
| “Free from the ingredients most commonly avoided during pregnancy” | Usually defensible | Factual and framed as consumer preference, if the list is stated |
| “Fragrance free” or “essential oil free” | Defensible | Verifiable composition statement |
| “Dermatologist tested” | Defensible with evidence | Requires the actual test report in the PIF |
| “Suitable for sensitive skin” | Defensible with evidence | Needs substantiation like any performance claim |
The pattern is consistent. Statements about what is in your product are verifiable and defensible. Statements about what your product does for a pregnancy are not, because they cross into territory a cosmetic may not enter.
Free-from claims are not automatically safe either. The common criteria prohibit denigrating legally permitted ingredients, so “no nasty chemicals” or “free from toxic retinol” is challengeable even though “formulated without retinol” is not. State the fact, do not editorialise about the substance.
What a pregnancy-focused assessment adds
A standard CPSR assesses the product for its intended use by the general adult population. A pregnancy-focused assessment does that and then does more, which is why it is a genuinely more expensive piece of work rather than a premium for the label.
- Reproductive and developmental endpoints examined explicitly for each substance, rather than taken as read from a general safety conclusion.
- Conservative dermal absorption assumptions where systemic exposure is the concern being raised.
- A targeted review of the substances of concern: retinoids, BHAs, phytoestrogens, flagged essential oil constituents and endocrine-active substances under review.
- An assessment of the claims themselves against the common criteria, so the wording on the pack is checked alongside the formula.
The claim assessment is the part brands usually did not expect and usually need most. It is also the part that a standard CPSR does not include, because a safety report concludes on safety rather than on marketing.
Bringing it all together
This is a genuine and growing market segment served badly by an industry that either ignores it or overclaims into it. The honest position is narrower than most brands would like and far more durable: you can say precisely what your formula does not contain, you can substantiate what it does, and you can be transparent about the fact that no cosmetic can promise an outcome for a pregnancy.
Customers in this segment are unusually well informed. A brand that explains its ingredient policy clearly and does not overreach earns more trust than one that stamps a badge on the box. The badge is also the thing a regulator or a competitor will pick up first.
Lexora’s pregnancy cosmetics safety assessment is a full CPSR plus a targeted reproductive and developmental review and an honest read on the claims you intend to make. If the formula is settled and only the wording is in question, a standalone cosmetic claims compliance check assesses your claims against Regulation (EU) No 655/2013. If you are still formulating, a formula screening will tell you where the substances of concern sit before you commit.
Frequently asked questions
Can I put “pregnancy safe” on my packaging?
It is risky as an unqualified claim. It has to satisfy the common criteria in Regulation (EU) No 655/2013, it must not imply a medical benefit or reassurance, and it must not suggest that other products are unsafe. A factual statement about what the formula omits is far easier to defend than a claim about what it is safe for.
Is there an EU certification for pregnancy-safe cosmetics?
No. There is no legal category, no authorisation route and no regulator certification for cosmetics in pregnancy. Any third-party seal is a private scheme, and using it does not change your obligations under Regulation (EC) No 1223/2009 or shield the claim from challenge under the common criteria.
Which ingredients should a pregnancy-positioned range avoid?
The ones this customer group actually screens for: retinoids and other vitamin A derivatives, salicylic acid and other beta hydroxy acids at leave-on treatment levels, phytoestrogens such as genistein and daidzein, substances flagged for endocrine activity, and essential oils traditionally avoided in pregnancy. Whether to exclude each is a commercial choice, but you should make it deliberately and be able to state it.
Is retinol banned in EU cosmetics?
No. Regulation (EU) 2024/996 set maximum concentrations for vitamin A in cosmetics, with a lower limit for body lotion than other leave-on products because of the applied amount. Being within the limit is a general population question. Whether to include it in a range marketed to pregnant customers is a separate commercial and positioning decision.
How is this different from a standard CPSR?
It is a full CPSR plus two additions: reproductive and developmental endpoints examined explicitly for each substance rather than inherited from a general conclusion, and an assessment of the pregnancy-related claims you intend to make against Regulation (EU) No 655/2013. Both are real work, which is why the service sits above the standard tier.
Can I say “free from harmful chemicals”?
No. That wording denigrates legally permitted ingredients and implies a safety differential you cannot substantiate, both of which the common criteria prohibit. “Formulated without retinol, salicylic acid and essential oils” states the same fact without the editorial and is defensible because it is verifiable.
Do I need a separate assessment for a pregnancy version of an existing product?
If the formula has changed, yes, because it is a different product. If the formula is identical and only the marketing has changed, the safety conclusion may carry over but the claims still need assessing, since the claim is the new element and the claim is where the legal exposure sits.
